BRKR - Bruker - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1167941087
Scientific Instruments, Analytical Solutions, Diagnostic Tools, Microscopy Systems
Bruker Corporation is a leading developer, manufacturer, and distributor of cutting-edge scientific instruments and analytical solutions that cater to a wide range of industries, including life sciences, pharmaceuticals, and materials research. With a strong global presence, the company operates through four key segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
The company's product portfolio is diverse and extensive, featuring life science tools, single and multiple modality systems, and life science mass spectrometry solutions. Its MALDI Biotyper rapid pathogen identification platform and related test kits enable swift and accurate diagnosis of infectious diseases, including COVID-19. Additionally, Bruker offers genotype and fluorotype molecular diagnostics kits, as well as research, analytical, and process analysis instruments and solutions.
Bruker's range of portable analytical and bioanalytical detection systems, X-ray instruments, and analytical tools for electron microscopes enable researchers and scientists to conduct advanced analysis and testing. The company's atomic force microscopy instrumentation, non-contact nanometer resolution solution topography, and automated X-ray metrology solutions provide unparalleled insights into material properties and structures.
Furthermore, Bruker's advanced optical fluorescence microscopy instruments, products, and services support the multi-omics needs of researchers in translational research, drug, and biomarker discovery. The company's superconducting materials, devices, and complex tools based on metallic low temperature superconductors, as well as non-superconducting high technology tools, such as synchrotron and beamline instrumentation, are used in various applications, including materials science and quantum computing.
Founded in 1991, Bruker Corporation is headquartered in Billerica, Massachusetts, and has established itself as a trusted partner for scientists, researchers, and industries worldwide. With a strong commitment to innovation and customer satisfaction, the company continues to push the boundaries of scientific discovery and technological advancement.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
BRKR Stock Overview
Market Cap in USD | 8,858m |
Sector | Healthcare |
Industry | Medical Devices |
GiC SubIndustry | Life Sciences Tools & Services |
TER | 0.00% |
IPO / Inception | 2000-08-04 |
BRKR Stock Ratings
Growth 5y | 18.7 |
Fundamental | 14.5 |
Dividend | 43.1 |
Rel. Performance vs Sector | -1.21 |
Analysts | 4.08/5 |
Fair Price Momentum | 63.89 USD |
Fair Price DCF | 27.70 USD |
BRKR Dividends
Dividend Yield 12m | 0.34% |
Yield on Cost 5y | 0.42% |
Dividends CAGR 5y | 4.56% |
Payout Consistency | 96.7% |
BRKR Growth Ratios
Growth Correlation 3m | -41.2% |
Growth Correlation 12m | -47.7% |
Growth Correlation 5y | 52.8% |
CAGR 5y | 4.98% |
CAGR/Mean DD 5y | 0.26 |
Sharpe Ratio 12m | 0.21 |
Alpha vs SP500 12m | -32.32 |
Beta vs SP500 5y weekly | 0.98 |
ValueRay RSI | 48.23 |
Volatility GJR Garch 1y | 35.15% |
Price / SMA 50 | -5.25% |
Price / SMA 200 | -15.75% |
Current Volume | 1346.6k |
Average Volume 20d | 1485.3k |
External Links for BRKR Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of November 08, 2024, the stock is trading at USD 60.49 with a total of 1,346,625 shares traded.
Over the past week, the price has changed by +6.85%, over one month by -8.28%, over three months by +0.39% and over the past year by +4.12%.
According to ValueRays Forecast Model, BRKR Bruker will be worth about 69.9 in November 2025. The stock is currently trading at 60.49. This means that the stock has a potential upside of +15.62%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 76.1 | 25.8 |
Analysts Target Price | 77.8 | 28.6 |
ValueRay Target Price | 69.9 | 15.6 |